Breakwater Capital Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $926K | Buy |
11,161
+7,068
| +173% | +$586K | 0.15% | 140 |
|
|
2025
Q1 | $332K | Sell |
4,093
-1,173
| -22% | -$95.1K | 0.06% | 260 |
|
|
2024
Q4 | $474K | Buy |
5,266
+744
| +16% | +$67K | 0.09% | 187 |
|
|
2024
Q3 | $447K | Buy |
4,522
+1,185
| +36% | +$117K | 0.09% | 186 |
|
|
2024
Q2 | $309K | Buy |
3,337
+1,123
| +51% | +$104K | 0.07% | 216 |
|
|
2024
Q1 | $210K | Buy |
+2,214
| New | +$210K | 0.05% | 252 |
|